Hermetica Superfood Encyclopedia
The Short Answer
Ascophyllan is a sulfated polysaccharide from Ascophyllum nodosum that exerts antioxidant and immunomodulatory effects and competitively inhibits intestinal α-glucosidase, thereby slowing glucose absorption. In vitro assays of A. nodosum aqueous ethanolic extracts containing ascophyllan demonstrate α-glucosidase inhibition with an IC50 of approximately 77 μg/mL against rat intestinal enzyme, alongside 73–79% ABTS radical scavenging activity, though no human clinical trials have yet been conducted on the isolated compound.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordascophyllan benefits
Ascophyllan — botanical close-up
Health Benefits
**Blood Glucose Modulation**
Ascophyllan contributes to competitive inhibition of intestinal α-glucosidase (IC50 ≈ 77 μg/mL in rat intestinal enzyme assays), slowing the hydrolysis of complex carbohydrates and potentially attenuating postprandial glucose spikes.
**Antioxidant Activity**: A
nodosum extracts enriched with ascophyllan and phlorotannins demonstrate ABTS radical scavenging of 73.2–79.0% in sprouting seed models, attributed to the sulfate groups on the polysaccharide backbone and co-extracted phenolics providing electron-donating capacity.
**α-Amylase Inhibition**: At 0
01% A. nodosum extract (ANE) concentration, extracts containing ascophyllan achieve approximately 67.16% ± 0.9% α-amylase inhibition at 24 hours, suggesting a complementary mechanism for carbohydrate digestion modulation alongside α-glucosidase inhibition.
**Immunomodulatory Potential**
In cell-based assays, isolated ascophyllan modulates LPS-stimulated immune responses in a concentration-dependent manner at microgram-per-milliliter doses, suggesting interaction with innate immune signaling pathways, though precise receptor targets remain to be characterized.
**Tyrosinase Inhibition**: A
nodosum extracts achieve up to 88.0% ± 2.11% tyrosinase inhibition at 36 hours, indicating potential anti-melanogenic and skin-protective properties that may involve the sulfated polysaccharide fraction including ascophyllan.
**Anti-Allergic Properties**
Ascophyllan has been classified among the bioactive sulfated polysaccharides of A. nodosum with reported anti-allergic activity in preliminary research, possibly through modulation of mast cell degranulation or histamine release pathways, though mechanistic data remain limited.
**Plant Biostimulant Effects**: In agricultural applications, ANE at 0
01–0.05% significantly enhances endogenous antioxidant enzyme activity and phenolic biosynthesis in treated seeds and plants, reflecting the broader bioactivity of the polysaccharide-rich extract, with ascophyllan among the active constituents.
Origin & History
Natural habitat
Ascophyllan is a sulfated polysaccharide isolated from Ascophyllum nodosum, a brown macroalga (rockweed) native to the cold, nutrient-rich coastal waters of the North Atlantic Ocean, particularly abundant along the shores of Norway, Iceland, Ireland, Scotland, and the northeastern United States and Canada. The seaweed thrives in the intertidal zone, anchoring to rocky substrates and tolerating wide salinity and temperature fluctuations. Commercial harvesting of A. nodosum is conducted primarily in Norway and Ireland, where the biomass is sustainably collected and processed into dried meal, liquid extracts, and isolated polysaccharide fractions for agricultural biostimulant and nutraceutical research applications.
“Ascophyllum nodosum has been harvested by coastal communities in Norway, the British Isles, and Atlantic Canada for centuries, primarily as a soil amendment and animal fodder rather than a medicinal herb, with Icelandic and Norwegian farmers historically applying dried or composted rockweed to poor agricultural soils to improve fertility and crop yields. In Irish and Scottish coastal traditions, various seaweeds including rockweed were consumed as food and used as rudimentary remedies for iodine deficiency, joint complaints, and thyroid conditions, though ascophyllan as a distinct molecular entity was neither identified nor intentionally utilized in these traditional contexts. The systematic scientific characterization of A. nodosum's polysaccharide constituents, including the identification and partial isolation of ascophyllan as a discrete sulfated fucan fraction, is a product of twentieth and twenty-first century marine natural products chemistry rather than traditional ethnobotanical knowledge. Modern interest in ascophyllan has emerged from the broader scientific effort to characterize marine-derived sulfated polysaccharides as bioactive ingredients, inspired by the commercial success of fucoidan and carrageenan research from other brown and red algae.”Traditional Medicine
Scientific Research
The scientific evidence base for isolated ascophyllan is extremely limited and consists exclusively of in vitro enzyme inhibition assays, cell-based immunomodulation models, and plant/seed germination studies; no peer-reviewed human or animal pharmacokinetic or efficacy trials have been published on the isolated compound as of current available literature. In vitro data from A. nodosum extract studies demonstrate meaningful enzyme inhibitory activity (α-glucosidase IC50 ≈ 77 μg/mL; α-amylase inhibition ~67%; tyrosinase inhibition ~88%) and antioxidant capacity (ABTS scavenging 73–79%), but these figures reflect crude mixed extracts rather than purified ascophyllan, making compound-specific attribution uncertain. One study characterized ascophyllan's chemical composition and its concentration-dependent activity against LPS-stimulated cells, providing preliminary evidence of immunomodulatory bioactivity without elucidating specific signaling pathways or providing pharmacodynamic parameters. The overall body of evidence is preclinical, methodologically heterogeneous, and insufficient to establish efficacy, optimal dosing, or safety in humans, representing a significant gap that future isolated-compound clinical research must address.
Preparation & Dosage
Traditional preparation
**Crude A. nodosum Dried Meal**
Used in agricultural and animal nutrition contexts at variable concentrations; commercial dried meal contains approximately 44.7% carbohydrates, 5.2% protein, and 3.0% lipids by dry weight, with no standardized ascophyllan content declared.
**Aqueous Ethanolic Extract (Research Grade)**
Prepared by extracting dried A. nodosum biomass with aqueous ethanol, used at 0.01–0.05% (w/v) concentrations in in vitro and plant bioassay studies; not formulated for human supplementation.
**Alkaline Polysaccharide Extract**
Ascophyllan is isolated via alkaline extraction of A. nodosum biomass, yielding a sulfated polysaccharide fraction used in laboratory bioactivity characterization; no standardized purity or concentration specification for supplement use exists.
**Commercial Liquid Extracts (e.g., Maxicrop®)**
Seaweed-based biostimulant products derived from A. nodosum contain ascophyllan among a complex mixture of polysaccharides, phytohormones, and minerals; these are approved for agricultural use and are not intended or dosed for human consumption.
**Human Supplemental Dose**
No established or recommended human dose for isolated ascophyllan exists; any supplement containing A. nodosum extracts should be evaluated for total fucoidan and polysaccharide content rather than ascophyllan specifically until standardized isolation and dosing research is completed.
**Timing**
No evidence-based timing recommendations exist for ascophyllan; theoretical glucose-modulating effects would suggest pre-meal administration if future human studies confirm oral efficacy.
Nutritional Profile
As an isolated sulfated polysaccharide, ascophyllan does not function as a conventional macronutrient and contributes no significant caloric, protein, or lipid value in the trace quantities studied. Its parent material, dried A. nodosum meal, contains carbohydrates (44.7 ± 2.1% dw), ash (18.6 ± 0.9% dw, reflecting high mineral content including iodine, calcium, magnesium, and potassium), protein (5.2 ± 0.2% dw), and lipids (3.0 ± 0.1% dw). Key phytochemical constituents of the whole seaweed matrix include alginic acid (~28% dw), fucoidans (~11.6–25.9% dw depending on extraction method), mannitol (7.5–21.0% dw), laminarin (4.5–7.3% dw), and phlorotannins (~1.4–12.6% dw), with ascophyllan representing a subfraction of the total sulfated polysaccharide pool whose precise proportion is not quantified in available literature. Bioavailability of intact sulfated polysaccharides like ascophyllan following oral ingestion is expected to be low due to limited intestinal absorption of high-molecular-weight polymers, with biological effects likely occurring primarily at the luminal level through enzyme inhibition rather than systemic distribution.
How It Works
Mechanism of Action
Ascophyllan, as a sulfated fucan-type polysaccharide, exerts its primary documented pharmacological action through competitive inhibition of intestinal α-glucosidase, an enzyme responsible for hydrolyzing oligosaccharides to absorbable monosaccharides at the brush border of the small intestine; this inhibition reduces and delays the rate of glucose entry into the portal circulation. The negatively charged sulfate groups distributed along the polysaccharide chain are believed to interact electrostatically with the active site of α-glucosidase and potentially α-amylase, mimicking substrate binding without undergoing cleavage. In cellular models, ascophyllan demonstrates concentration-dependent modulation of LPS-induced signaling at microgram-per-milliliter concentrations, implying possible interference with toll-like receptor 4 (TLR4)-mediated downstream pathways such as NF-κB activation, though this has not been confirmed with specific molecular probes. The antioxidant contribution of ascophyllan likely arises from the capacity of its sulfate ester groups and hydroxyl moieties to donate electrons and chelate pro-oxidant transition metal ions, complementing the phlorotannin fraction co-present in crude A. nodosum extracts.
Clinical Evidence
No clinical trials investigating ascophyllan as an isolated ingredient in human subjects have been identified in the current literature; the entirety of human-applicable data is extrapolated from in vitro enzyme assays and plant-based models using crude A. nodosum extracts. Outcomes that have been measured in preclinical and ex vivo systems include α-glucosidase and α-amylase inhibition percentages, ABTS radical scavenging capacity, tyrosinase inhibition, and LPS-modulated cell responses, all of which show biologically plausible but unvalidated signals. Effect sizes such as 88% tyrosinase inhibition or 79% ABTS scavenging are methodologically promising but were derived from low-concentration plant treatment experiments (0.01–0.05% ANE) with unspecified sample sizes, limiting statistical confidence. Confidence in any clinical benefit of ascophyllan specifically is very low; it should be regarded as a compound in early discovery-phase research rather than one with established therapeutic application.
Safety & Interactions
Ascophyllan as an isolated compound has no published human safety data, and all safety inferences must be drawn from studies of crude A. nodosum extracts, which are considered generally safe at low concentrations (0.01–0.05% in agricultural applications) with no reported toxicity at these levels. Whole A. nodosum consumption carries recognized risks of excessive iodine intake, which can precipitate thyroid dysfunction including hyperthyroidism or hypothyroidism, particularly in individuals with pre-existing thyroid conditions or those taking thyroid hormone replacement therapy; this concern applies to high-dose seaweed supplements but has not been specifically evaluated for isolated ascophyllan. No drug interaction data exist for ascophyllan specifically; however, its α-glucosidase inhibitory activity theoretically suggests potential additive hypoglycemic effects if combined with antidiabetic medications such as metformin, acarbose, or insulin secretagogues, warranting caution and blood glucose monitoring in diabetic individuals. Pregnancy and lactation safety is unstudied; given the absence of human trials and the theoretical risk of iodine excess from seaweed-derived preparations, use during pregnancy or breastfeeding is not recommended without medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ascophyllum nodosum sulfated polysaccharideRockweed polysaccharideA. nodosum fucanANE polysaccharide fractionKnotted wrack extract
Frequently Asked Questions
What is ascophyllan and where does it come from?
Ascophyllan is a sulfated polysaccharide—a long-chain carbohydrate with attached sulfate groups—isolated from Ascophyllum nodosum, a brown seaweed (rockweed) harvested from the cold coastal Atlantic waters of Norway, Ireland, Scotland, and northeastern North America. It is one of several bioactive polysaccharides in this seaweed, alongside fucoidans, laminarin, and alginic acid, and is distinguished by its specific sugar composition and sulfation pattern. Unlike fucoidans, which have been more extensively researched, ascophyllan remains a relatively novel research compound without established commercial supplement formulations.
Does ascophyllan help control blood sugar levels?
In vitro laboratory studies using A. nodosum aqueous ethanolic extracts containing ascophyllan have demonstrated competitive inhibition of intestinal α-glucosidase with an IC50 of approximately 77 μg/mL, and approximately 67–85% inhibition of α-amylase and α-glucosidase in sprouting seed assays at 0.01% extract concentrations. These enzyme inhibitory effects suggest a theoretical mechanism for slowing carbohydrate digestion and reducing postprandial blood glucose, similar to the pharmaceutical drug acarbose. However, no human clinical trials have confirmed this effect in people, so ascophyllan cannot currently be recommended as a blood sugar management supplement.
Is ascophyllan safe to take as a supplement?
Isolated ascophyllan has no published human safety or toxicology data, and all available safety information comes from crude A. nodosum extract studies, which show no adverse effects at very low concentrations (0.01–0.05%) used in agricultural and laboratory settings. Individuals with thyroid disorders should exercise caution with any A. nodosum-derived product due to the seaweed's naturally high iodine content, which can interfere with thyroid hormone production. People taking antidiabetic medications should also seek medical advice before using ascophyllan-containing products, as additive blood glucose-lowering effects are theoretically possible.
How is ascophyllan different from fucoidan?
Both ascophyllan and fucoidan are sulfated polysaccharides found in A. nodosum and other brown seaweeds, but they differ in their specific monosaccharide composition, degree of sulfation, molecular weight, and branching structure, which results in distinct but sometimes overlapping bioactivities. Fucoidan has been studied far more extensively, with hundreds of in vitro, animal, and some human trials documenting antithrombotic, antiviral, antitumor, and immunomodulatory effects, while ascophyllan research is in very early stages with only a handful of published studies. In the whole seaweed, fucoidan comprises approximately 11.6–25.9% of dry weight depending on extraction method, whereas ascophyllan's proportion within the total polysaccharide fraction has not been precisely quantified.
What forms of ascophyllan supplements are available?
Currently, no consumer supplement products are specifically standardized for isolated ascophyllan content; the compound exists primarily as a research-grade isolated polysaccharide used in laboratory studies. Consumers can find A. nodosum whole seaweed meal, powder, or liquid extracts in supplement and agricultural biostimulant markets (such as Maxicrop®), which contain ascophyllan as part of a complex mixture of polysaccharides, minerals, and phytochemicals without declared ascophyllan concentrations. Until standardized extraction, isolation, and human clinical research establishes effective doses and safety parameters, ascophyllan cannot be considered a ready-to-use supplement ingredient in the conventional sense.
What does the research show about ascophyllan's effectiveness for blood sugar control?
Scientific studies demonstrate that ascophyllan competitively inhibits α-glucosidase enzymes in the intestine (with an IC50 value around 77 μg/mL in animal models), which slows the breakdown and absorption of complex carbohydrates. This mechanism can help reduce post-meal blood sugar spikes, though most evidence comes from laboratory and animal studies rather than large-scale human trials. Human clinical research on ascophyllan specifically remains limited, so more studies are needed to confirm optimal dosing and real-world effectiveness in people.
How does ascophyllan compare to other brown seaweed extracts for antioxidant protection?
Ascophyllan works synergistically with other compounds in Ascophyllum nodosum, particularly phlorotannins, to provide antioxidant protection—with ABTS radical scavenging activity demonstrating significant free radical neutralization. While ascophyllan is a key polysaccharide component, the antioxidant potency of brown seaweed extracts depends on the concentration and combination of multiple bioactive compounds present. Other seaweed extracts like fucoidan may offer different antioxidant profiles and mechanistic pathways, making the choice dependent on your specific health goals.
Who is most likely to benefit from taking an ascophyllan supplement?
Ascophyllan supplements may be most beneficial for individuals seeking natural support for postprandial glucose management, particularly those concerned with blood sugar stability or metabolic health. People interested in antioxidant support and general wellness from whole-food-derived polysaccharides may also find value in ascophyllan supplementation. Those with existing blood sugar medications or conditions should consult a healthcare provider before use to ensure compatibility and appropriate dosing.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ascophyllan-ascophyllum-nodosum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
